ASCENTAGE (06855): Trustee purchased 200,000 shares for the 2022 Restricted Share Unit Plan
Ascentage Pharma (06855) announced that on October 27, 2026, the trustee purchased a total of 200,000 existing shares on-market (the purchased shares) for the purpose of the 2022 Restricted Share Unit Plan to satisfy restricted share units upon vesting.
ASCENTAGE (06855) announced that on October 27, 2026, the trustee purchased a total of 200,000 existing shares on-market (the purchased shares) for the purpose of the 2022 Restricted Share Unit Plan to satisfy restricted share units upon vesting.
Related Articles
OCUMENSION-B (01477): Fluocinolone acetonide intravitreal implant approved by the National Medical Products Administration for production in mainland China
AI computing power demand overwhelms advanced packaging capacity! Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) reportedly plans to raise prices by 10-20%, putting cost pressure on NVIDIA Corporation and Apple Inc.
AEON STORES (00984) subsidiary enters into lease agreement for Guangzhou property
OCUMENSION-B (01477): Fluocinolone acetonide intravitreal implant approved by the National Medical Products Administration for production in mainland China
AI computing power demand overwhelms advanced packaging capacity! Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) reportedly plans to raise prices by 10-20%, putting cost pressure on NVIDIA Corporation and Apple Inc.
AEON STORES (00984) subsidiary enters into lease agreement for Guangzhou property
